As of 30 Sep 2025, 24 institutional investors reported holding 1,335,118 shares of Hoth Therapeutics, Inc. - COM NEW (HOTH).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,001 | $1,981 | +$1,981 | $0.99 | 1 |
| 2025 Q3 | 1,335,118 | $2,161,606 | +$1,747,450 | $1.62 | 24 |
| 2025 Q2 | 264,713 | $309,692 | -$36,952 | $1.17 | 14 |
| 2025 Q1 | 304,176 | $303,734 | +$61,202 | $1.00 | 16 |
| 2024 Q4 | 243,673 | $182,285 | -$112,479 | $0.75 | 14 |
| 2024 Q3 | 366,257 | $322,270 | +$9,339 | $0.88 | 11 |
| 2024 Q2 | 348,508 | $317,471 | -$131,344 | $0.91 | 10 |
| 2024 Q1 | 493,113 | $749,532 | +$630,409 | $1.52 | 9 |
| 2023 Q4 | 78,706 | $113,335 | -$26,906 | $1.44 | 9 |
| 2023 Q3 | 96,008 | $145,575 | -$7,882 | $1.52 | 9 |
| 2023 Q2 | 71,329 | $213,987 | +$73,832 | $3.00 | 9 |
| 2023 Q1 | 60,445 | $122,032 | -$1,160,008 | $2.03 | 10 |
| 2022 Q4 | 169,115 | $1,318,890 | +$1,318,890 | $7.90 | 10 |